Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 354 participants.
Also called NCT06308952
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 354 participants
- Sponsor
- Beijing Tiantan Hospital
- Dongguan People's Hospital
- Eighth Affiliated Hospital, Sun Yat-sen University
- First Affiliated Hospital of Chongqing Medical University
- First Affiliated Hospital of Harbin Medical University
- First Affiliated Hospital of Jinan University
- Peking Union Medical College Hospital
- Shanxi Cardiovascular Hospital
- Shenzhen Second People's Hospital
- The First Affiliated Hospital of Zhengzhou University
- Tianjin Huanhu Hospital
- Xinqiao Hospital of Chongqing
- ZhuHai Hospital
- Registry
-
NCT06308952
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06308952. Randomized; quadruple masking; primary purpose prevention. Start 2024-07-30 (actual); primary completion 2027-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
- Condition
- Cerebrovascular Event
- Condition
- Stent Stenosis
- Condition
- Ischemic Stroke
- Condition
- Hemorrhagic Stroke
- Condition
- Stent Thrombosis
- Condition
- Death, Brain
- Condition
- Endothelial Dysfunction
- Intervention (Drug)
- Atorvastatin 20mg
- Lead sponsor
- Duan Chuanzhi
- Collaborator
- Shenzhen Second People's Hospital
- Collaborator
- First Affiliated Hospital of Harbin Medical University
- Collaborator
- ZhuHai Hospital
- Collaborator
- First Hospital of Shijiazhuang City
- Collaborator
- Eighth Affiliated Hospital, Sun Yat-sen University
- Collaborator
- First Affiliated Hospital of Jinan University
- Collaborator
- Dongguan Kanghua Hospital
- Collaborator
- Beijing Tiantan Hospital
- Collaborator
- Guangdong 999 Brain Hospital
- Collaborator
- The First Affiliated Hospital of Zhengzhou University
- Collaborator
- First Affiliated Hospital of Chongqing Medical University
- Collaborator
- Dongguan People's Hospital
- Collaborator
- Xinqiao Hospital of Chongqing
- Collaborator
- Shanxi Cardiovascular Hospital
- Collaborator
- Peking Union Medical College Hospital
- Collaborator
- Tianjin Huanhu Hospital
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 13
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 95 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 16 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 25 trials in this atlas.
Record details
- Record id
cardio:ct-nct06308952- Content hash
df847e76f9391a23aab949b3e2d0fcacc5deaf97dd18c36a8aec3c57dc243543